Investment Strategy
The best of income and growth
Fidelity Monthly Income Fund offers a unique combination of high yielding equity and fixed-income securities, actively managed to aim to deliver a balance of income and growth.
Fidelity Monthly Income Fund
Performance
Annual compound performance – as at 31-Dec-2011
| Fund | Morningstar Quartile* |
Benchmark | |
| 1 month | 1.55% | 1 | 1.82% |
| 3 month | 4.50% | 1 | 3.78% |
| 6 month | 0.50% | 1 | 2.57% |
| 1 year | 5.97% | 1 | 6.78% |
| 2 year | 8.73% | 1 | 9.77% |
| 3 year | 14.89% | 1 | 15.48% |
| 5 year | 4.85% | 1 | 5.81% |
| 7 year | 7.41% | 1 | 7.14% |
| 10 year | — | — | — |
| YTD | 5.97% | 1 | 6.78% |
| Since Inception | 7.92% | — | 7.54% |
Calendar year performance – as at 31-Dec-2011
Growth of $10,000 since inception – as at 31-Jan-2012
Fund risk measures – as at 31-Dec-2011
| Fund | Benchmark | |
| Annual Standard Deviation | 6.92 | 6.49 |
| Beta | 0.98 | — |
| R² | 0.85 | — |
Risk measures are based on 3-year net returns (series B). (All returns are calculated in Canadian currency.)
Volatility meter
The volatility meter uses methodology recommended by the Fund Risk Classification Task Force of the Investment Funds Institute of Canada. The Task Force prescribes risk assessment based on historical volatility risk as measured by the standard deviation of fund performance. The Task Force also acknowledges that other types of measurable and nonmeasurable risk may exist. The Task Force reminds investors that historical performance may not be indicative of future returns and a fund’s historical volatility may not be indicative of future volatility.
View other Fidelity funds in this category:
Fund facts
NAVPU – Series B
$13.81 – as at 07-Feb-2012
Fund inception date
06-Nov-2003
Fund benchmark
Blended index**
Fund aggregate assets (all series)
$5.075 billion
as at 31-Jan-2012
Management expense ratio - Series B
2.09% – as at 30-Jun-2011
Quarterly Top Ten Holdings
| Fairfax Financial Holdings, Sub Vtg | |
| Toronto-Dominion Bank | |
| Shoppers Drug Mart | |
| Rogers Communication, Cl. B, Non Vtg | |
| Metro, Cl. A, Sub Vtg | |
| BP PLC SPON ADR | |
| THOMSON REUTERS CORP | |
| AstraZeneca | |
| Best Buy | |
| Aetna | |
| Total number of holdings | 1,651 |
| Total equity holdings | 201 |
| Total bond holdings | 1,439 |
| Top 10 holdings aggregate | 14.4% |
Allocation to funds